The number of cancer biomarkers continues to grow, providing new opportunities for oncologists to care for cancer patients. Whether a patient diagnosis be non-small cell lung cancer (NSCLC) or colorectal cancer, guidelines, such as NCCN or ASCO endorse genomic testing of biomarkers to improve patient outcomes. However, how many cancer patients actually receive this testing?
In this informative webinar, real-world data expert and Chief Medical Officer at Cota Healthcare, Dr. C.K. Wang, answers this question based on two recent studies using data from day-to-day clinical care of oncology patients in lung and colorectal cancer. Additionally, Dr. Wang describes the value of real-world data and how healthcare institutions can use these data to improve routine cancer care.
By attending this webinar, you will: